Ozempic and Mounjaro made $71B last year, about four times OpenAI and Anthropic
Healthcare AI Guy notes the haul came while only around 2% of people with obesity worldwide take the drugs.
Recap by typeshit. Post by Healthcare AI Guy on X.
Healthcare AI Guy notes the haul came while only around 2% of people with obesity worldwide take the drugs.
Recap by typeshit. Post by Healthcare AI Guy on X.
Keltie Knight shares a personal take on body image pressure on women, tagged with GLP-1 and BookTok. It's a short social clip with few specifics.
8:41
The weekly tirzepatide update marks a milestone for the channel, with the scale finally dipping below 220 pounds.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
Alberts presented on peptides at the Rheumatology Update for the Clinician conference, a brief shoutout with no findings shared.
Among the items: Walmart plans free GLP-1 diabetes drugs for employees in 2027, and Verdiva Bio dropped a phase II oral GLP-1 study citing market changes.
Loading…